Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Mianserin

A tetracyclic antidepressant that acts mainly by blocking alpha-2 adrenergic, serotonin and histamine receptors: patented in the Netherlands in 1967, it has been on the market since the mid-1970s. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.

Did you know?Mirtazapine, a newer antidepressant, is almost a copy of it: it differs only by one nitrogen atom in place of a carbon in one of the rings, so much so that it is also called 6-aza-mianserin.

MianserinGo to the active ingredient →
MianserinActive ingredientMianserinCat. No. P-M119-001CAS 24219-97-4

EDQM standards 3

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.